Search results
Australia’s Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement | World News -...
Indian Express· 5 hours agoMayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to...
Sun Pharma share price hits 52-week high, despite getting sued by Australia’s Mayne Pharma, over...
Livemint· 8 hours agoSun Pharmaceutical's share price hit its 52-week high on July 25, 2024, at ₹1,658.00, on NSE. Mayne ...
Cipla To Sun Pharma: gRevlimid To Drive Q1 Sales Growth For Pharma, Say Analysts
NDTV Profit· 1 day agoHere's what brokerages expect for the pharma sector in first quarter of fiscal 2025.
Mayne Pharma Sues Sun Pharma in Patent Dispute | India Infoline
India Infoline· 10 hours agoThe Australian pharmaceutical company Mayne Pharma announced on Thursday that it has launched a case in a U.S. court alleging patent infringement against Sun</ ...
Mankind Pharma frontrunner to acquire Bharat Serums in $1.5 bn deal
Business Standard India· 10 hours agoMankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a...
Stocks in news: Adani Green, ITC, Axis Bank, L&T, RBL Bank, DRL, Sun Pharma, RVNL and IEX
Business Today· 14 hours agoCompanies including Adani Green, ITC, Axis Bank, Larsen & Toubro, RBL Bank, Sun Pharma, Dr Reddy's,...
Stock market update: Nifty Pharma index advances 0.94%
The Economic Times· 6 hours agoThe Nifty Pharma index closed 0.94 per cent up at 21105.5.
Akums Drugs and Pharma's Rs 1,857 cr-IPO to open on July 30
The Economic Times· 11 hours agoAkums Drugs and Pharma IPO: Akum Drugs and Pharmaceuticals set a price band of Rs 646 to Rs 679 per...
Akums, India’s largest domestic-focused CDMO player, is all set to tap the capital market - ET...
The Economic Times· 16 hours agoAs per its RHP, Akums proposes to utilise the net proceeds from the fresh issue of equity shares for...
Pharma stocks rise in anticipation of hike in Budget expenditure for healthcare, aid to R&D
CNBC Awaaz· 3 days agoPharmaceutical stocks rose amid expectations of increased healthcare spending and R&D support in the...